-
Study aim
-
Determining the effect of adding magnesium sulfate, dexmedetomidine and midazolam to bupivacaine with the caudal method in postoperative control of pain in 2-8 year old children who are candidates for lower abdominal surgery.
-
Design
-
Clinical trial, without control group, with three parallel groups, double-blind, randomized, phase 3 on 90 patients, for randomization, sealed envelope method is used.
-
Settings and conduct
-
The study will be conducted in Valiasr, Amir al-Mominin and Amir Kabir Arak hospitals. Randomization and then allocation of patients to the mentioned groups is done by the responsible anesthesia technician. Then the caudal anesthesia is performed by the anesthesiologist who only knows the drugs with labels on them.
-
Participants/Inclusion and exclusion criteria
-
The participants are children aged between 2 to 8 years old who are candidates for lower abdominal surgery. No emergency surgery or a surgery longer than 90 minutes is included; the participants are categorized as ASA classes I and II, have no previous history of hypersensitivity to the medications used in this study or suffer from renal, cardiac and congenital diseases. If a patient has to be multiple punctured, they are also omitted from the study.
-
Intervention groups
-
This study consists of three groups of 30 participants (total of 90 participants), that have been randomized in a double-blind fashion. The first group receives Bupivacaine(0.25%, 0.5 ml/kg) with Magnesium Sulfate(50 μg/kg), the second group receives Bupivacaine with Dexmedetomidine(1 μg/kg) and the third group receives Bupivacaine with Midazolam(50 μg/kg). Then the pain experienced by each group in analyzed with VAS and CHEOPS score.
-
Main outcome variables
-
VAS and CHEOPS score will be different among the three groups, the incident of vomiting, chills, additional analgesic consumption and vital signs might be different among three groups.